Pharma
The alliance will center on the discovery, development and commercialization of radioligand therapies for imaging and treatment of solid tumors.
Ozempic and Wegovy pens will be available via GoodRx for $499 per month.
Maven Clinic introduces male fertility support tools, Scripta Insights announces a tool to locate cost-effective meds, and XRHealth launches a new platform.
Also, Neurophet will tap into Roche's data to further improve its brain scan analysis AI.
The company said it plans to develop its new Chai‑2 platform to design, from square one, completely new antibodies for viruses and cancer.
Foundation Health's AI platform will automate patient outreach and communication workflows at Intermountain Health's specialty pharmacy operations.
The company will utilize the funds to accelerate the development of its clinical diagnostic platform and expand its partnerships with pharmaceutical and biotechnology firms.
Proceeds will go to settling debts and focusing on its business in the United States.
The spin-off company is expected to rake in almost $2 billion in revenue this year.
Patients will get same-day delivery and access to treatments like GLP-1s and hormone therapies.